Eli Lilly’s lepodisiran slashes inherited heart disease risk factor by 94% in Phase 2 trial
Eli Lilly (NYSE:LLY) released positive Phase 2 results for its small interfering RNA (siRNA) drug candidate lepodisiran on ...
KSTP26m
Asian shares are sharply lower, Tokyo and Taiwan tumble 4%, after Wall Street retreat
Asian shares are sharply lower, with benchmarks in Tokyo and Taiwan falling more than 4% after Wall Street had another ...